Jiajun Liu
United States Food and Drug Administration(US)Sun Yat-sen University(CN)The First People's Hospital of Guiyang(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)Shanxi Academy of Medical Sciences(CN)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing, Acute Kidney Injury Research
Most-Cited Works
- → JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial(2017)271 cited
- → The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer(2019)124 cited
- → Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis*(2017)124 cited
- → A Review of the Clinical Pharmacokinetics of Polymyxin B(2019)115 cited
- → Mechanisms of antimicrobial-induced nephrotoxicity in children(2019)80 cited
- → Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention(2020)72 cited